Study on the Medication Characteristics and Combination Rules of Medicinals in the Treatment of Chronic Nephritis with Chinese Herbal Compound Formula based on China Patent Announcement
|更新时间:2023-07-27
|
Study on the Medication Characteristics and Combination Rules of Medicinals in the Treatment of Chronic Nephritis with Chinese Herbal Compound Formula based on China Patent Announcement
Journal of Traditional Chinese MedicineVol. 64, Issue 15, Pages: 1538-1543(2023)
XIE Jiadong,HE Weiming,HE Jiayi,et al.Study on the Medication Characteristics and Combination Rules of Medicinals in the Treatment of Chronic Nephritis with Chinese Herbal Compound Formula based on China Patent Announcement[J].Journal of Traditional Chinese Medicine,2023,64(15):1538-1543.
XIE Jiadong,HE Weiming,HE Jiayi,et al.Study on the Medication Characteristics and Combination Rules of Medicinals in the Treatment of Chronic Nephritis with Chinese Herbal Compound Formula based on China Patent Announcement[J].Journal of Traditional Chinese Medicine,2023,64(15):1538-1543.DOI: 10.13288/j.11-2166/r.2023.15.006.
Study on the Medication Characteristics and Combination Rules of Medicinals in the Treatment of Chronic Nephritis with Chinese Herbal Compound Formula based on China Patent Announcement
To analyze the medication characteristics and combination rule of medicinals of Chinese herbal compound formulas in the treatment of chronic nephritis based on the China Patent Announcement.
Methods
2
We first collected the patents of Chinese herbal compound formulas for the treatment of chronic nephritis from China Patent Announcement Network. The use of herbal medicine was calculated, and Python was used to classify the functions, nature, flavors and channel entry of high-frequency herbs; the association rules of Chinese herbal compound formulas were analyzed based on R language; SPSS 22.0 software was used for high-frequency herbs cluster analysis; Cytoscape 3.9 was used to build a complex network and show the relevance of potential new formulas and herbs.
Results
2
A total of 249 patents of Chinese herbal compound formulas were included, involving 671 herbs. Top five high-frequency herbs included Huangqi (
Radix Astragali
, 112 times), Fuling (
Poria
, 94 times), Baizhu (
Rhizoma Atractylodis Macrocephalae
, 76 times), Yimucao (
Herba Leonuri
, 63 times), and Dangshen (
Radix et Rhizoma Salviae Miltiorrhizae
, 61 times). The categories were mainly deficiency supplementing herbs (573 times), urination promoting and dampness percolating herbs (248 times), and blood invigorating and stasis dissolving herbs (237 times). The nature and flavors were mainly cold (917 times), warm (804 times), sweet (1699 times) and bitter (986 times), and channel entry was mostly liver (1226 times), spleen (1063 times), kidney (1045 times) and lung (1032 times). High-frequency herbal cluster analysis obtained five herbal combinations, which were (1) Nyuzhenzi (
Fructus Ligustri Lucidi
), Tusizi (
Semen Cuscutae
), Yinyanghuo (
Herba Epimedii
), Dahuang (
Radix et Rhizoma Rhei
), Yiyiren (
Semen Coicis
); (2) Honghua (
Flos Carthami
), Taoren (
Semen Persicae
), Niuxi (
Radix Achyranthis Bidentatae
); (3) Chenpi (
Pericarpium Citri Reticulatae
), Duzhong (
Cortex Eucommiae
), Cheqianzi (
Semen Plantaginis
); (4) Shanzhuyu (
Fructus Corni
), Shiwei (
Folium Pyrrosiae
); (5) Shengdihuang (
Rhizoma Radix Rehmanniae
), Mudanpi (
Cortex Moutan
). Commonly used pairs of herbs were Huangqi-fuling, Huangqi-baizhu, and Baizhu-fuling, and the three-herb combination was Huangqi-baizhu-fuling. The core herbs were Huangqi, Baizhu, Baimaogen (
Rhizoma Imperatae
), Gancao (
Radix et Rhizoma Glycyrrhizae
), Shanyao (
Rhizoma Dioscoreae
), Zexie (
Rhizoma Alismatis
), Danggui (
Radix Angelicae Sinensis
), Yimucao, Dahuang, Cheqianzi.
Conclusion
2
The high-frequency herbs and commonly used herbal combinations of Chinese herbal compound formulas for the treatment of chronic nephritis in China Patent Announcement are centered on supplementing deficiency, draining dampness, and promoting blood circulation, which are basically consistent with the current understanding of the pathogenesis of chronic nephritis.
CHEN Y , DENG Y , NI Z , et al . Efficacy and safety of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial [J]. Am J Kidney Dis , 2013 , 62 ( 6 ): 1068 - 1076 .
ZHONG Y , DENG Y , CHEN Y , et al . Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases [J]. Kidney Int , 2013 , 84 ( 6 ): 1108 - 1118 .
Laws of Syndrome Evolution of Type 2 Diabetes Mellitus and the Medication Characteristics based on Community Discovery Algorithm in Complex Network
Analysis on Medication Characteristics of Shenfu Injection for Critical Illness Based on Hospital Information System
Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"
Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity:from a Real-World Research Perspective
Similarities and Differences between Myofascial Trigger Points and Sinew Knot:from the Perspective of the Channel Sinew Theory
Related Author
Ying XING
Min PI
Runshun ZHANG
Baoyan LIU
Tiancai WEN
YANG Jing
XIE Yanming
LI Lin
Related Institution
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
Shenzhen Traditional Chinese Medicine Hospital
Guang'anmen Hospital,China Academy of Chinese Medical Sciences